Europe Faces Long Wait for Weight-Loss Drugs

Novo Nordisk will start selling its hugely popular obesity drug Wegovy in Germany this month but only people who pay from their own pocket or have certain private health insurance plans will be able to get it.
Reuters Health Information

source https://www.medscape.com/s/viewarticle/994159?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?